[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360072-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360072-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","prognostic-factors-in-oropharyngeal-cancer-treated-with-definitive-chemoradiotherapy","Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy","","HPV-negative oropharyngeal squamous cell cancer (OPSCC) is linked to unfavorable clinical outcomes, motivating evaluation of prognostic determinants in patients treated with definitive chemoradiotherapy (CTRT). Consecutive OPSCC cases managed with definitive CTRT from January 2013 to December 2017 were analyzed retrospectively. Survival was assessed with Kaplan–Meier; univariate and multivariate models used log-rank and Cox regression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/prognostic-factors-in-oropharyngeal-cancer-treated-with-definitive-chemoradiotherapy/360072/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/prognostic-factors-in-oropharyngeal-cancer-treated-with-definitive-chemoradiotherapy/360072.png","ImageObject",300,407,{"name":42,"@type":43},"Rizky","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the primary objective of this study?","Question",{"text":63,"@type":64},"To evaluate prognostic factors for OPSCC treatment outcomes after definitive chemoradiotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were survival and prognostic effects analyzed?",{"text":68,"@type":64},"Kaplan–Meier was used for survival; log-rank for univariate analysis; Cox regression for multivariate analysis.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were identified as independent prognostic indicators for poor locoregional control?",{"text":72,"@type":64},"KPS ≤80, p16 negative tumors, T3–T4 stage, advanced AJCC stage, conventional RT technique, RT dose \u003C66 Gy EQD2, and residual disease after treatment.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360072,1790193055,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962085564807,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Cancer Medicine  \n|  RESEARCH ARTICLE  OPEN ACCESS \u003Cbr>Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy\u003Cbr>Sheetal R. Kashid1 | Ashwini Budrukkar1  | Monali Swain1 | Sarbani Ghosh Laskar1  | Vedang Murthy1 | Tejpal Gupta1 Ajay Sasidharan1 | Vijay Patil2 | Amit Joshi2 | Vanita Noronha2 | Neha Mittal3 | Manoj Mahimkar4,5 | Asawari Patil3 | Usha Patel4,5 | Shwetabh Sinha1 | Anuj Kumar1 | Nandini Menon2 | Munita Bal3 | Kumar Prabhash2 |\u003Cbr>Jai Prakash Agarwal1 \u003Cbr>1Department of Radiation Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India | 2Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India | 3Department of Pathology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India | 4Mahimkar Lab, Cancer Research Institute, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India | 5Homi Bhabha National Institute, Mumbai, India\u003Cbr>Correspondence: Ashwini Budrukkar ([budrukkaran@tmc.gov.in](budrukkaran@tmc.gov.in))\u003Cbr>Received: 10 September 2025 | Revised: 7 April 2026 | Accepted: 13 April 2026\u003Cbr>Keywords: chemoradiotherapy | head and neck oncology | head and neck squamous cell carcinoma | HPV | HPV negative oropharyngeal cancer | human papillomavirus | oral cancer | oropharyngeal cancer |  |  |\n| --- | --- | --- |\n| ABSTRACT\u003Cbr>Objectives: HPV-negative oropharyngeal squamous cell cancer (OPSCC) is associated with poor clinical outcomes. The main objective of this study was to evaluate prognostic factors of OPSCC treated with definitive chemoradiotherapy (CTRT) . Materials and Methods: Consecutive patients of OPSCC treated with definitive CTRT in a tertiary care center from January 2013 to December 2017 were analysed retrospectively. Kaplan–Meier method was used for survival analysis, Log-rank test was used for univariate analysis (UVA), and Cox regression method was used for multivariate analysis (MVA) .\u003Cbr>Results: Out of 630 eligible patients, 543 (86 . 1%) had locally advanced stage according to AJCC 7th edition. HPV status was known for 500 patients, of which 55 (11%) tested p16 positive, reflecting a predominantly HPV-negative cohort. Chemo-radiotherapy was offered to 447 (71%) patients. Intensity-modulated-radiotherapy (IMRT) technique was used for 163 (25.9%) patients. On UVA KPS ≤80 (p = 0.001), p16 negative tumours (p \u003C 0 .001), T3-T4 stage (p \u003C 0 .001), advanced group stage (AJCC 8th ed.) (p \u003C 0 .001), conventional RT technique (p \u003C 0.001), RT dose \u003C 66 Gy EQD2 (p \u003C 0.001) and residual disease after treatment (p \u003C 0.001) were associated with poor Locoregional control (LRC) rates. On MVA p16 negative tumours (HR 3.1 [95% CI 1.8–5.3]), T3-T4 stage (HR 1.6 [95% CI 1.2–2.2]), conventional RT technique (HR 1.6 [95% CI 1.5–2.3]), RT dose \u003C 66 Gy EQD2 (HR 2.2 [95% CI 1.5–3.4]) were independent prognostic factors for poor LRC. These variables were also significant for local control, disease-free free and overall survival. Conclusion: In this predominantly HPV-negative OPSCC cohort, HPV status, T stage, RT technique, and RT doses >66 Gy were independent prognostic factors for all outcomes. |  |  |\n| 1 | Introduction |  | treatment outcomes shaped by the intricacies of disease biol- |\n| Oropharyngeal cancer, comprising 6.5% of neck cancers [1], presents an intriguing | all head and\u003Cbr>landscape in | ogy. Unravelling its prognosis involves a multifaceted interplay of elements. Factors such as Human Papilloma Virus (HPV) status, tumour stage, nodal involvement, histological grade, |\n| This study was partly presented at ESTRO 2022, Copenhagen, Denmark.\u003Cbr>Ashwini Budrukkar and Sheetal Kashid are responsible for statistical analysis. |  |  |\n| This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non","cbCaimGGVLNaAisp","https://ap.wps.com/l/cbCaimGGVLNaAisp","pdf",686963,11,"English","# Abstract\n## Introduction\n## Materials and Methods","[{\"question\":\"What was the primary objective of this study?\",\"answer\":\"To evaluate prognostic factors for OPSCC treatment outcomes after definitive chemoradiotherapy.\"},{\"question\":\"How were survival and prognostic effects analyzed?\",\"answer\":\"Kaplan–Meier was used for survival; log-rank for univariate analysis; Cox regression for multivariate analysis.\"},{\"question\":\"Which factors were identified as independent prognostic indicators for poor locoregional control?\",\"answer\":\"KPS ≤80, p16 negative tumors, T3–T4 stage, advanced AJCC stage, conventional RT technique, RT dose \\u003c66 Gy EQD2, and residual disease after treatment.\"}]","Prognostic Factors in Oropharyngeal Cancer Treated With Definitive Chemoradiotherapy | PDF",1790138684,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c27cab0abc789130409bbc63e7aee90c.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dffcdbf364355c18dc867b4c93f57733.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d97f8f11c514a98efb54fca04827d44.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7b129d40ddb411fd123bfd28c9501ef1.webp",980,1287]